Cargando…
Multi-Omics Perspective Reveals the Different Patterns of Tumor Immune Microenvironment Based on Programmed Death Ligand 1 (PD-L1) Expression and Predictor of Responses to Immune Checkpoint Blockade across Pan-Cancer
Immune checkpoint inhibitor (ICI) therapies have shown great promise in cancer treatment. However, the intra-heterogeneity is a major barrier to reasonably classifying the potential benefited patients. Comprehensive heterogeneity analysis is needed to solve these clinical issues. In this study, the...
Autores principales: | Huang, Kaitang, Hu, Meiling, Chen, Jiayun, Wei, Jinfen, Qin, Jingxin, Lin, Shudai, Du, Hongli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8153013/ https://www.ncbi.nlm.nih.gov/pubmed/34068143 http://dx.doi.org/10.3390/ijms22105158 |
Ejemplares similares
-
Characterization of Glycolysis-Associated Molecules in the Tumor Microenvironment Revealed by Pan-Cancer Tissues and Lung Cancer Single Cell Data
por: Wei, Jinfen, et al.
Publicado: (2020) -
Roles of Proteoglycans and Glycosaminoglycans in Cancer Development and Progression
por: Wei, Jinfen, et al.
Publicado: (2020) -
Relapsing Polychondritis following PD-1 Blockade by an Immune Checkpoint Inhibitor
por: Mutoh, Tomoyuki, et al.
Publicado: (2023) -
Immune checkpoint blockade: the role of PD-1-PD-L axis in lymphoid malignancies
por: Ilcus, Cristina, et al.
Publicado: (2017) -
The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies
por: Petitprez, Florent, et al.
Publicado: (2020)